SEC Form 4 · accession 0001209191-15-052694
OCULAR THERAPEUTIX, INC · OCUL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James M Garvey
Director
Period of report
Jun 11, 2015
Accepted (ET)
Jun 12, 2015 · 2:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001393434
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $22.54 | Jun 11, 2015 | A | 5,681 | A | Jun 11, 2016 | Jun 10, 2025 | Common Stock | 5,681 | 5,681 | D |
Explanation of responses
- F1Subject to Reporting Person's continued service on the Issuer's Board of Directors, the stock option will vest and become exercisable in full on the first anniversary of the date of grant.